Lynn Shao, based in Shanghai, leads Egon Zehnder’s Health Practice in China. Lynn brings strong business insights when solving clients’ leadership challenges, leveraging both her experience of working as a strategy consultant serving healthcare industry and hands-on commercial leadership experience in pharmaceutical industry. She is actively involved in Board and Executive Search, Leadership Assessment and Development.
I am energized by connecting with talented people, understanding what motivates them and helping maximize their leadership potential, who then bring transformational impact to increasingly dynamic business and industry.
Prior to joining Egon Zehnder, Lynn was the Strategic Marketing & Business Operations Director at Sanofi China, where her responsibilities included strategic and new product planning, digital innovation, and operations excellence for the company’s diabetes business unit. Before that she served as an Engagement Manager at McKinsey & Co., advising clients on topics such as market entry, growth strategy, M&A target screening and integration.
Lynn earned a BS and a Master’s of Management degree from Fudan University in Shanghai and then an MBA from the Wharton Business School at the University of Pennsylvania.
邵玲玲是亿康先达中国健康产业咨询团队的负责人，常驻上海。她充分发挥战略咨询顾问的专业背景和在医药行业的丰富实践经验，为中国本土及全球客户提供人才和领导力发展的专业咨询服务和决策支持。她专注于高管继任和寻访，在领导力评估与发展、董事会效能评估及独立董事寻访亦有丰富经验。
能够与有才之士交流、探寻驱使其前进的动力、并帮助其充分发挥领导潜力，从而助力他们对日新月异的企业和行业产生深远的影响力，这样的工作让我倍感振奋。
加入亿康先达之前，邵玲玲曾任赛诺菲战略营销与业务运营总监，其职责包括赛诺菲糖尿病药物业务单元的战略产品/新产品发布、数字化创新和卓越运营职能。职业早年，她曾任麦肯锡项目经理，为中外客户提供市场准入、自然成长/并购式成长战略和并购后整合领域的专业咨询。
邵玲玲是复旦大学理学士和管理学硕士，美国宾夕法尼亚大学沃顿商学院MBA。
